Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.56 and traded as low as $0.51. Elite Pharmaceuticals shares last traded at $0.56, with a volume of 1,988,049 shares changing hands.
Elite Pharmaceuticals Stock Down 0.3 %
The firm has a market capitalization of $596.42 million, a PE ratio of -55.83 and a beta of 0.25. The stock has a 50-day simple moving average of $0.56 and a 200-day simple moving average of $0.37. The company has a quick ratio of 2.42, a current ratio of 3.52 and a debt-to-equity ratio of 0.10.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Recommended Stories
- Five stocks we like better than Elite Pharmaceuticals
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- What Are Trending Stocks? Trending Stocks Explained
- How AI Implementation Could Help MongoDB Roar Back in 2025
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
